The main SGLT2 inhibitor Xenia (empagliflozin and its combos) was introduced by USV, an Indian global healthcare business, to treat type 2 diabetes patients' heart failure, chronic renal disease, and glycaemic management.
LONDON, UK - March 19: The much-anticipated second annual edition of the Biotechnology Show continues to attract industry giants, creating a powerful platform for innovation, collaboration, and deal-making.
HaystackAnalytics has launched 'TB One,' a Make-in-India solution aimed at improving TB diagnosis through next-generation sequencing (NGS) in any diagnostic laboratory or hospital.
According to clinical trial results published in The Lancet Haematology, a locally created CAR T-cell immunotherapy has demonstrated a 73% response rate in patients with leukemia and lymphoma, marking a significant achievement for cancer therapy in I
The application of AI in medicine for early diagnoses, and especially cancer prediction, has been acknowledged to be a significant scientific achievement. In India...
Sun Pharmaceutical Industries subsidiary TARO Pharmaceuticals Inc. has completed the 100% acquisition of Antibe Therapeutics Inc., a...
AstraZeneca announced that it has made a deal to take over EsoBiotec, a biotechnology company focused on in vivo cell therapies. EsoBiotec has come up with a new way of using engineered...
Morepen Laboratories Limited has announced the introduction of Empamore, a revolutionary medication for Chronic Kidney Disease (CKD), Heart Failure with Reduced Ejection Fraction (HFrEF), and Type 2 Diabetes Mellitus (T2DM).
By the end of this year, India will commence domestic manufacture of Rifampicin, a first-line anti-tubercular medicine. According to official sources, “Rifampicin is at an advanced stage of execution and is expected to get commissioned later this yea
Chronic Kidney Disease (CKD) is a growing public health crisis in India, affecting a significant percentage of the population and causing over 100,000 new cases of kidney failure annually. Despite its prevalence, early detection remains low, often le
, CDSCO.jpg)
